These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
353 related items for PubMed ID: 17692635
1. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores. Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V, Mennini G, Berloco PB. Transplant Proc; 2007; 39(6):1864-7. PubMed ID: 17692635 [Abstract] [Full Text] [Related]
2. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list. Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC. Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160 [Abstract] [Full Text] [Related]
3. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Cuomo O, Perrella A, Arenga G. Transplant Proc; 2008 Oct; 40(6):1906-9. PubMed ID: 18675085 [Abstract] [Full Text] [Related]
4. Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure. Novelli G, Rossi M, Ferretti G, Pugliese F, Travaglia D, Guidi S, Novelli S, Lai Q, Morabito V, Berloco PB. Transplant Proc; 2010 May; 42(4):1182-7. PubMed ID: 20534256 [Abstract] [Full Text] [Related]
8. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores. Teixeira AC, Souza FF, Sankarankutty AK, Martinelli AL, Castro E Silva O. Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738 [Abstract] [Full Text] [Related]
9. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease. Buenadicha AL, Martín LG, Martín EE, Pajares Ad, Pérez AM, Seral CC, Marugán RB. Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571 [Abstract] [Full Text] [Related]
10. One hundred sixteen cases of acute liver failure treated with MARS. Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, Nudo F, Bussotti A, Corradini S, Martelli S, Berloco PB. Transplant Proc; 2005 Nov; 37(6):2557-9. PubMed ID: 16182742 [Abstract] [Full Text] [Related]
12. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation. Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, Aranda JM, Rodríguez-Canete A, Gonzalez-Sanchez A. Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967 [Abstract] [Full Text] [Related]
14. Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications. Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, Chang FY, Lee SD. Clin Transplant; 2006 Oct; 20(2):188-94. PubMed ID: 16640525 [Abstract] [Full Text] [Related]